Management of STEMI and
High Risk ACS WebCAST

WebCAST CME Disclosure

Please read this notice and click the acknowledgement
at the bottom of the page to continue.

Release Date:

April 21, 2009

Expiration Date:

April 21, 2011

Intended Audience:

• Cardiologists
• Interventional Cardiologists
• Emergency medicine specialists
• Prehospital care providers
• Critical care physicians and intensivists
• Hospitalists
• Hospital Pharmacists

Registration:

Enrollment for this WebCAST is complimentary, and clinicians are invited to participate in this CME-certified WebCAST and/or share this invitation with other colleagues, departmental staff members, and healthcare professionals.

Grantor Support:

Supported by an independent
educational grant from
The Medicines Company.

Accreditation Statement:

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of The University of Massachusetts Medical School, Office of CME and CMEducation Resources, LLC. The University of Massachusetts Medical School is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement:

The University of Massachusetts Medical School designates this educational activity for a maximum of 2.0 AMA PRA Category 1 Credit(s). Physicians should only claim credit commensurate with the extent of their participation in the activity.

Policy on Faculty & Provider Disclosure:

It is the policy of the University of Massachusetts Medical School to ensure fair balance, independence, objectivity and scientific rigor in all activities. All faculty participating in CME activities sponsored by the University of Massachusetts Medical School are required to present evidence-based data, identify and reference off-label product use and disclose all relevant financial relationships with those supporting the activity or others whose products or services are discussed. Faculty disclosure will be provided in the activity materials.

Faculty Disclosures:

Sunil V. Rao, MD, FACC
Grant/Research Support: Cordis
Consultant: sanofi-aventis, The Medicines Company
Speaker’s Bureau: sanofi-aventis, The Medicines Company, Cordis

Gregg W. Stone, MD, FACC
Research Support: The Medicines Company
Honoraria: Eli Lilly

Ron Waksman, MD, FACC
Consultant and Speaker or Research Grant Support: Medtronic, Boston Scientific, Biotronik, GSK, sanofi-aventis, BMS

Harold L. Dauerman, MD
Consultant: The Medicines Company
Speaker’s Bureau: The Medicines Company

Program Faculty:

Program Chairman
Sunil V. Rao, MD, FACC
Host, Duke University Medical Center
Cardiac Catheterization Conference
Duke University Medical Center
Director, Cardiac Catheterization Laboratories
Durham VA Medical Center
Durham, North Carolina

Harold L. Dauerman, MD, FACC
Director, Cardiovascular Catheterization Laboratories
Professor of Medicine
University of Vermont Medical Center
Fletcher Allen Health Care
Burlington, Vermont

Ron Waksman, MD, FACC
Associate Director, Division of Cardiology Washington Hospital Center
Director, Experimental Angioplasty &
Vascular Brachytherapy
Cardiovascular Research Institute
Washington Hospital Center
Clinical Professor of Medicine
Georgetown University
Washington, DC

Gregg W. Stone, MD, FACC
Professor of Medicine
Columbia University
Director of Cardiovascular Research and Education
Center for Interventional Vascular Therapy
Columbia University Medical Center
Chairman, The Cardiovascular Research Foundation
New York, New York

Educational Objectives:

Participants in this CME-certified WebCAST will:

• Learn to identify signs, symptoms, and prognostic features of STEMI and acute coronary syndrome and related ischemic conditions, and their implications for invasive vascular management.
• Learn how best to combine different stent types with antithrombotic and antiplatelet therapy.
• Learn how invasive procedures recommended in the AHA/ACC Guidelines for STEMI and high risk Non ST-Elevation Myocardial Infarction are best applied to appropriately risk-stratified patients with UA and NSTEMI.
• Learn to assess and implement optimal pharmacologic interventions, especially antithrombotic therapy in the upstream setting, for patients presenting with manifes tations of UA, NSTEMI, STEMI, and related conditions.
  

Disclaimer:

Copyright © 2009 by Pharmatecture, LLC and CMEducation Resources, LLC All rights reserved.

Reproduction, distribution, or translation without express written permission is strictly prohibited.

Content on this webcast reflects the opinions, output, and analyses of experts, investigators, educators, and clinicians whose activities for, while independent, are commercially supported by the sponsor noted at the start of each activity.
Content on this webcast is not meant to be, nor substitute for national guidelines or recommendations generated by professional, academic societies, colleges, or associations.

Content on this webcast is intended for educational value only. Its contents, analyses, and any recommendation made herein are intended to make scientific information and opinion available to health professionals, to stimulate thought, and further investigation. This webcast is not designed nor is any aspect of the contents here intended to provide advice regarding medical diagnosis or treatment for any individual case. Any decisions regarding diagnosis and/or management of any individual patient or group of patients should be made on individual basis after having consulted appropriate sources, whether they be appropriate consultants and/or guidelines and recommendations issued by national organizations, professional societies, governmental health organizations, or similar bodies. This webcast is not intended for use by the layman.

Opinions expressed herein are not necessarily those of Pharmatecture, LLC, CMEducation Resources, LLC, program supporters or accreditors, but reflect the opinions and analyses of the experts who have authored the material. Mention of products or services does not constitute endorsement. Clinical, legal, financial, and other comments are offered for general guidance only; and professional counsel should be sought for all specific situations.

Copyright © 2008 All rights reserved